Issue 3/2019
Content (13 Articles)
AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs
Hiroshi Asanuma, Hyemoon Chung, Shin Ito, Kyung-Duk Min, Madoka Ihara, Hiroko Takahama, Marina Funayama, Miki Imazu, Hiroki Fukuda, Akiko Ogai, Yoshihiro Asano, Tetsuo Minamino, Seiji Takashima, Toshisuke Morita, Masaru Sugimachi, Masanori Asakura, Masafumi Kitakaze
Combination Therapy of Pulmonary Arterial Hypertension with Vardenafil and Macitentan Assessed in a Human Ex Vivo Model
Markus Hoenicka, Svitlana Golovchenko, Leonie Englert, Mirjam Spaeth, Levani Shoshiashvili, Christian Großer, Hans-Stefan Hofmann, Michael Ried
Plasma from Volunteers Breathing Helium Reduces Hypoxia-Induced Cell Damage in Human Endothelial Cells—Mechanisms of Remote Protection Against Hypoxia by Helium
Kirsten F. Smit, Gezina T. M. L. Oei, Moritz Konkel, Quinten J. J. Augustijn, Markus W. Hollmann, Benedikt Preckel, Hemal H. Patel, Nina C. Weber
Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review
Carles Moliner-Abós, Mercedes Rivas-Lasarte, Julia Pamies Besora, Paula Fluvià-Brugues, Eduard Solé-González, Sonia Mirabet, Laura López López, Vicens Brossa, Maria José Pirla, Nuria Mesado, Jesús Álvarez-García, Eulàlia Roig
“Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
Joanne Simpson, L. Benson, P. S. Jhund, U. Dahlström, J. J. V. McMurray, L. H. Lund
Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
Prasad S. Nishtala, Hamish A. Jamieson, H. Carl Hanger, Te-yuan Chyou, Sarah N. Hilmer
Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients
Ka-Po Fung, Kei-Hong Chan, Vivien Ng, Ping-Tim Tsui, Joyce H. S. You
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis
Saurabh Gupta, Kevin J. Um, Arjun Pandey, William F. McIntyre, Marina Ivanova, Yasamin Allahverdi, Parisa Agahi, Feny Pandya, Ana Lopez, Amrit Sachdeva, Richard P. Whitlock, Emilie P. Belley-Cote
Association of Elevated Plasma Homocysteine Level with Restenosis and Clinical Outcomes After Percutaneous Coronary Interventions: a Systemic Review and Meta-analysis
Zhipeng Zhang, Shan Xiao, Changqiang Yang, Runyu Ye, Xianjin Hu, Xiaoping Chen
Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design
Miki Imazu, Atsushi Nakano, Shin Ito, Toshimitsu Hamasaki, Masafumi Kitakaze
HDL-Targeted Therapies During Myocardial Infarction
Andrei C. Sposito, Helison R. Carmo, Joaquim Barreto, Lufan Sun, Luiz Sergio F. Carvalho, Steve B. Feinstein, Ilaria Zanotti, Anatol Kontush, Alan Remaley
HFREF Patients and Atrial Fibrillation: Time to Reconsider the Appropriateness of the Atrial Fibrillation Ablation in This Patient Subset?
Renato De Vecchis